 |
|
| Personal data sheet |
 Print previewVALIDITY EXPIRED
personal data approved: 2014. V. 01. | Publications |
2014
 from data base, 2014. V. 01. |
Haller J, Aliczki M, Pelczer KG, Spitzer K, Balogh Z, Kantor S: Effects of the fatty acid amide hydrolase inhibitor URB597 on coping behavior under challenging conditions in mice., PSYCHOPHARMACOLOGY 231: pp. 593-601.
type of document: Journal paper/Article
impact factor: 4.061**
language: English
DOI |
2013
from data base, 2014. V. 01. |
Kantor S, Szabo L, Varga J, Cuesta M, Morton AJ: Progressive sleep and electroencephalogram changes in mice carrying the Huntington's disease mutation., BRAIN 136: (Pt 7) pp. 2147-2158. Paper 23801737.
type of document: Journal paper/Article
impact factor: 9.915*
language: English
DOI |
2013
from data base, 2014. V. 01. |
Kantor S, Mochizuki T, Lops SN, Ko B, Clain E, Clark E, Yamamoto M, Scammell TE: Orexin gene therapy restores the timing and maintenance of wakefulness in narcoleptic mice., SLEEP 36: (8) pp. 1129-1138.
type of document: Journal paper/Article
impact factor: 5.100*
language: English
DOI |
2013
from data base, 2014. V. 01. |
Kantor S, Szabo L, Varga J, Cuesta M, Morton J: Sleep and EEG as biological markers in animal models of Huntington's disease, ACTA PHARMACOLOGICA SINICA 34: (S) p. 107. 1 p. Paper S10.33.
type of document: Journal paper/Konferenciaközlemény
language: English
|
2009
from data base, 2014. V. 01. |
Kantor S, Mochizuki T, Janisiewicz AM, Clark E, Nishino S, Scammell TE: Orexin neurons are necessary for the circadian control of REM sleep., SLEEP 32: (9) pp. 1127-1134.
type of document: Journal paper/Article
impact factor: 5.402
number of independent citations: 2
language: English
URL |
2005
from data base, 2014. V. 01. |
Kantor S, Jakus R, Molnar E, Gyongyosi N, Toth A, Detari L, Bagdy G: Despite similar anxiolytic potential, the 5-hydroxytryptamine 2C receptor antagonist SB-242084 [6-chloro-5-methyl-1-[2-(2-methylpyrid-3-yloxy)-pyrid-5-yl carbamoyl] indoline] and chlordiazepoxide produced differential effects on electroencephalogram power spectra, JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS 315: (2) pp. 921-930.
type of document: Journal paper/Article
impact factor: 4.098
number of independent citations: 11
language: English
DOI |
2004
from data base, 2014. V. 01. |
Balogh B, Molnar E, Jakus R, Quate L, Olverman HJ, Kelly PAT, Kantor S, Bagdy G: Effects of a single dose of 3,4-methylenedioxymethamphetamine on circadian patterns, motor activity and sleep in drug-naive rats and rats previously exposed to MDMA, PSYCHOPHARMACOLOGY 173: (3-4) pp. 296-309.
type of document: Journal paper/Article
impact factor: 3.146
number of independent citations: 27
language: English
DOI |
2004
from data base, 2014. V. 01. |
Kantor S, Jakus R, Balogh B, Benko A, Bagdy G: Increased wakefulness, motor activity and decreased theta activity after blockade of the 5-HT2B receptor by the subtype-selective antagonist SB-215505, BRITISH JOURNAL OF PHARMACOLOGY 142: (8) pp. 1332-1342.
type of document: Journal paper/Article
impact factor: 3.325
number of independent citations: 20
language: English
DOI |
2001
from data base, 2014. V. 01. |
Bagdy G, Graf M, Anheuer ZE, Modos EA, Kantor S: Anxiety-like effects induced by acute fluoxetine, sertraline or m-CPP treatment are reversed by pretreatment with the 5-HT2C receptor antagonist SB-242084 but not the 5-HT1A receptor antagonist WAY-100635, INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY 4: (4) pp. 399-408.
type of document: Journal paper/Article
impact factor: 2.779
number of independent citations: 140
language: English
URL |
2001
from data base, 2014. V. 01. |
Kantor S, Graf M, Anheuer ZE, Bagdy G: Rapid desensitization of 5-HT1A receptors in Fawn-Hooded rats after chronic fluoxetine treatment, EUROPEAN NEUROPSYCHOPHARMACOLOGY 11: (1) pp. 15-24.
type of document: Journal paper/Article
impact factor: 2.437
number of independent citations: 20
language: English
DOI |
| | Number of independent citations to these publications: | 220 |
|
|
|
|
|
Login
helka.iif.hu
